EV / EBITDA společnosti Theratechnologies
Jaká je hodnota metriky EV / EBITDA společnosti Theratechnologies?
Hodnota metriky EV / EBITDA společnosti Theratechnologies, Inc. je N/A
Jaká je definice metriky EV / EBITDA?
EV/EBITDA je podniková hodnota dělená EBITDA (zisk před odečtením úroků, daní, odpisů a amortizací). Měří nákladnost akcie a používá se k porovnání společností mezi sebou častěji než P/E ratio. Měří cenu, jakou investor zaplatí za pohyb hotovosti ve společnosti.
Price to earnings ratios are impacted by a company's choice of capital structure - companies which raise money via debt will have lower P/Es (and therefore look cheaper) than companies that raise an equivalent amount of money by issuing shares, even though the two companies might have equivalent enterprise values. A sample case is when a company with debt were to raise money by issuing shares of stock, and then used the money to pay off the debt, this company's P/E ratio would shoot up because of the increased number of shares - although nothing about the fundamental value of the business has changed. EV / EBITDA is unaffected by capital structure as enterprise value includes the value of debt, and EBITDA is available to all investors (debt and equity) as it excludes interest payments on that debt. It is ideal for analysts and potential investors looking to compare companies within the same industry.
EV / EBITDA společností v sektoru Health Care sektor na TSX ve srovnání se společností Theratechnologies
Čemu se věnuje společnost Theratechnologies?
Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant HIV-1 infected patients. Its pipeline products include F8 Formulation for the treatment of lipodystrophy in people living with HIV; TH-1902 for the treatment of triple negative breast cancer; and TH-1904 for the treatment of ovarian cancer. The company was incorporated in 1993 and is headquartered in Montreal, Canada.
Firmy s metrikou ev / ebitda podobnou společnosti Theratechnologies
- Hodnota metriky EV / EBITDA společnosti Avira Resources je N/A
- Hodnota metriky EV / EBITDA společnosti Avalon GloboCare je N/A
- Hodnota metriky EV / EBITDA společnosti Westport Fuel Systems je N/A
- Hodnota metriky EV / EBITDA společnosti Sequana Medical NV je N/A
- Hodnota metriky EV / EBITDA společnosti Mint Payments je N/A
- Hodnota metriky EV / EBITDA společnosti FRX Innovations je N/A
- Hodnota metriky EV / EBITDA společnosti Theratechnologies je N/A
- Hodnota metriky EV / EBITDA společnosti Bubblr Inc je N/A
- Hodnota metriky EV / EBITDA společnosti Mithra Pharmaceuticals SA je N/A
- Hodnota metriky EV / EBITDA společnosti Auxly Cannabis je N/A
- Hodnota metriky EV / EBITDA společnosti Spey Resources Corp je N/A
- Hodnota metriky EV / EBITDA společnosti Golden Deeps je N/A
- Hodnota metriky EV / EBITDA společnosti Red Lion Hotels je N/A